Cardio-Obstetrics

Questions discussed in this category

For pregnant patients in their first trimester presenting with acute MI with plan for emergent angiogram, who then subsequently have resolution of chest pain and EKG changes following initiation of heparin gtt, DAPT, would you still consider proceeding with LHC or treat medically with presumptive diagnosis of SCAD?

1 Answer available

Should we begin using bromocriptine for CVD management during pregnancy per ESC guidelines in patients with peripartum cardiomyopathy?

1 Answer available

What are your top takeaways from AHA 2023?

4 Answers available

How would you approach the management of a patient with a new diagnosis of cardiomyopathy in pregnancy without clinical signs of heart failure?

4 Answers available

Should bare metal stents be favored over drug eluting stents for pregnant patients presenting with acute coronary syndrome?

1 Answer available

Should all pregnant patients with newly reduced LVEF <45% be referred as soon as possible to advanced heart failure given high risk for maternal morbidity/mortality in setting of suspected peripartum cardiomyopathy?

If PPCM is suspected, what are your targeted hemodynamic goals during the delivery phase?

1 Answer available

What is your approach to postpartum screening and cardiovascular risk assessment in patients with a prior history of preeclampsia?

Recent AHA guidelines state that all women who have had a diagnosis of preeclampsia in a prior pregnancy should receive an evaluation of cardiac risk....

1 Answer available

What are high-risk clinical and echocardiographic features in pregnant patients with congenital heart disease?

1 Answer available

Should patients of advanced maternal age (>35 years of age) undergo routine cardiovascular risk stratification with echocardiogram during pregnancy?

1 Answer available

How do you counsel high-risk women with congenital heart disease who are looking to conceive?

1 Answer available

Papers discussed in this category

Eur Heart J,

2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy.

European heart journal, 2017 Sep 14

Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study.

European heart journal, 2020 Oct 14

Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry.

Trends in cardiovascular medicine, 2019-04

Peripartum cardiomyopathy-diagnosis, management, and long term implications.

European heart journal, 2021 Aug 21

Peripartum cardiomyopathy: from genetics to management.

Cardiac failure review, 2018 Aug

Postpartum Cardiomyopathy and Considerations for Breastfeeding.

Circulation, 2011 Feb 14

Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association.

Circulation. Cardiovascular quality and outcomes, 2017 Feb 22

Preeclampsia and Future Cardiovascular Health: A Systematic Review and Meta-Analysis.

Clinical science (London, England : 1979), 2012 Jul

Pre-eclampsia and offspring cardiovascular health: mechanistic insights from experimental studies.

Circulation, 2023 Nov 13

Sudden Cardiac Death in National Collegiate Athletic Association Athletes: A 20-Year Study.

Circulation, 2023 Nov 11

Arrhythmic Risk In Biventricular Pacing Compared with Left Bundle Branch Area Pacing: Results From The International LBBAP Collaborative Study (I-CLAS).

Circulation. Cardiovascular quality and outcomes, 2023 Nov 06

Off-Label Dosing of Direct Oral Anticoagulants Among Inpatients with Atrial Fibrillation in the United States.

American heart journal, 2017 Apr 24

Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial.

The New England journal of medicine, 2023 Nov 11

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.

American heart journal, 2023 Mar 25

Screening for peripartum cardiomyopathies using artificial intelligence in Nigeria (SPEC-AI Nigeria): Clinical trial rationale and design.

JAMA, 2023 Nov 11

Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure: The ARIES-HM3 Randomized Clinical Trial.

American heart journal, 2020 Oct 13

Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction.

The New England journal of medicine, 2024 Apr 07

Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock.

Circulation, 2016-12-13

Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I).

American heart journal, 2022 May 17

Empagliflozin in patients post myocardial infarction rationale and design of the EMPACT-MI trial.

The New England journal of medicine, 2024 Apr 06

Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes.

Cardio-Obstetrics

Questions discussed in this category

Papers discussed in this category

Related Topics